Financial reports
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
9 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
Current reports
8-K
Foghorn Therapeutics Provides Financial Update for 2023 and 2024 Strategic Outlook
7 Mar 24
8-K
Regulation FD Disclosure
8 Feb 24
8-K
Departure of Directors or Certain Officers
17 Jan 24
8-K
Foghorn Therapeutics Highlights Clinical Program Updates and Research Progress and Provides Strategic Objectives for 2024
8 Jan 24
8-K
Foghorn Therapeutics Announces CFO Departure
3 Jan 24
8-K
Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update
2 Nov 23
8-K
Regulation FD Disclosure
8 Sep 23
8-K
Foghorn Therapeutics Announces First Patient Dosed in Phase 1 Combination Study of FHD-286 for Relapsed and/or Refractory AML
31 Aug 23
8-K
Termination of a Material Definitive Agreement
10 Aug 23
8-K
Foghorn Therapeutics Announces Chief Medical Officer Succession
8 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
8 May 23
424B5
Prospectus supplement for primary offering
15 Apr 22
POS AM
Prospectus update (post-effective amendment)
15 Apr 22
S-3
Shelf registration
14 Feb 22
S-8
Registration of securities for employees
14 Feb 22
S-8
Registration of securities for employees
15 Jan 21
424B4
Prospectus supplement with pricing info
26 Oct 20
424B4
Prospectus supplement with pricing info
23 Oct 20
S-1/A
IPO registration (amended)
22 Oct 20
8-A12B
Registration of securities on exchange
19 Oct 20
Other
UPLOAD
Letter from SEC
17 Aug 22
CORRESP
Correspondence with SEC
28 Jul 22
UPLOAD
Letter from SEC
14 Jul 22
EFFECT
Notice of effectiveness
20 Apr 22
EFFECT
Notice of effectiveness
15 Mar 22
CORRESP
Correspondence with SEC
10 Mar 22
UPLOAD
Letter from SEC
18 Feb 22
SEC STAFF
SEC staff action: Order
29 Oct 20
EFFECT
Notice of effectiveness
23 Oct 20
CERT
Certification of approval for exchange listing
22 Oct 20